Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03769012
Other study ID # 19BIHK
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date December 27, 2018
Est. completion date May 30, 2020

Study information

Verified date December 2018
Source Kemin Foods LC
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This proposed study is designed to assess the efficacy of a capsule containing beta-glucan taken orally daily as compared to a placebo capsule on the URTI symptoms, and the immune response change in marathon runners


Description:

At screening, an informed consent form will be given to the potential volunteer. They will be required to read the information and will be given the opportunity to seek more information if needed or provided with the option of taking the consent form home to review prior to making their decision. If agreeable, the volunteer will sign the consent form and receive a duplicate of the signed copy. Once consent has been obtained, the screening visit will proceed. Each volunteer will be sequentially assigned a screening number to be entered in the screening and enrollment log. Screening assessments include: review medical history, assess inclusion and exclusion criteria, vitals, study diary, URTI symptom questionnaire, bowel diary, and GI symptom questionnaire. The next visit will be scheduled 14 days prior to their marathon date (baseline). Participants will be reminded to complete URTI questionnaire, daily study diary, modified GI symptoms and bowel diary in advance of this baseline visit. At baseline participants will begin daily completion of study diaries, URTI questionnaires, daily bowel diaries, and GI tolerance questionnaires. In clinic subjects will complete mood and stress questionnaires, and blood sample for the analysis of CRP and NK cell activity. In addition, on the day of the marathon the participant will be instructed to complete a muscle soreness assessment. Two and four weeks post-marathon participants will return to the clinic for with unused investigational product, completed study diaries, daily URTI questionnaires, daily bowel diaries, and GI tolerance questionnaires. In clinic subjects will complete mood and stress questionnaires, and blood sample for the analysis of CRP and NK cell activity.


Recruitment information / eligibility

Status Completed
Enrollment 60
Est. completion date May 30, 2020
Est. primary completion date November 30, 2019
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 21 Years to 65 Years
Eligibility Inclusion Criteria: 1. Males and Females 21-65 years age 2. Body Mass Index (BMI) > 18 kg/m2 to < 34.99 kg/m2 3. Willing to wash-out for nutritional supplements known to affect immune function 4. Females of childbearing potential must agree to use a medically approved method of birth control and have a negative urine pregnancy test result. 5. Agree to keep lifestyle habits consistent 6. Currently registered to participate in a full marathon and on a training regimen 7. Healthy as determined by laboratory results, medical history, and physical exam 8. Has given voluntary, written, informed consent to participate in the study Exclusion Criteria: 1. Women who are pregnant, breastfeeding, or planning to become pregnant during the occurrence of the trial 2. Verbal confirmation of previous major gastrointestinal surgery or other major digestive disorder which may interfere with the absorption of nutrients 3. Participant has a known allergy to the test material's active or inactive ingredients 4. Chronic consumption of beta-glucan supplements 5. Consumption of anti-inflammatory medications known to affect immune function 6. On antibiotics within 4 weeks of baseline 7. Currently taking antipsychotic medications 8. Prebiotics and probiotics unless on a stable regimen 9. Verbal confirmation of Type I or Type II diabetes or clinically important renal, hepatic, cardiac, pulmonary, pancreatic, neurologic, or biliary disorder, or cancer to be assessed by QI 10. Verbal confirmation of a diagnosed chronic inflammatory condition 11. Verbal confirmation of autoimmune disease or if immune-compromised 12. Chronic recurring respiratory signs and symptoms due to allergies (including seasonal allergies) or chronic bronchitis, asthma, or wheezing 13. Current or history (within past 6 months) of tobacco use 14. Consumption of >14 standard alcoholic drinks per week

Study Design


Intervention

Dietary Supplement:
Beta-Glucan
95% beta-glucan sourced from whole cell Euglena Gracilis
Placebo
microcrystalline cellulose

Locations

Country Name City State
Canada KGK Science Inc. London Ontario

Sponsors (2)

Lead Sponsor Collaborator
Kemin Foods LC KGK Science Inc.

Country where clinical trial is conducted

Canada, 

Outcome

Type Measure Description Time frame Safety issue
Primary Global Cold/Flu Symptom Severity Score Wisconsin Upper Respiratory Symptom Survey (WURSS) AUC for cold/flu symptoms from Wisconsin Upper Respiratory Symptom Score ANOVA with 2 and 4 weeks post-marathon
Secondary URTI Cold/Flu Symptoms from Wisconsin Upper Respiratory Symptom Survey Total number of symptoms ANOVA with 2 and 4 weeks post-marathon
Secondary Severity of cold/flu symptoms from Wisconsin Upper Respiratory Symptom Survey Total severity score (each symptom scored on scale of 0-no symptom to 7-severe symptom) ANOVA with 2 and 4 weeks post-marathon
Secondary URTI Episodes from Wisconsin Upper Respiratory Symptom Survey Total number of URTI Episodes/person ANOVA with 2 and 4 weeks post-marathon
Secondary Sick days Total number of sick days/person ANOVA with 2 and 4 weeks post-marathon
Secondary Sick days Percentage of subjects with sick days ANOVA with 2 and 4 weeks post-marathon
Secondary Stress Level from the perceived stress scale Change from baseline on the Perceived Stress Scale ANOVA with 2 and 4 weeks post-marathon
Secondary C-Reactive Protein Change in concentration from baseline ANOVA with 2 and 4 weeks post-marathon
Secondary Natural Killer Cell Activity Change from baseline ANOVA with 2 and 4 weeks post-marathon
Secondary Gastrointestinal symptoms Total gastrointestinal symptom rating score (GSRS) ANOVA with 2 and 4 weeks post-marathon
See also
  Status Clinical Trial Phase
Completed NCT05130944 - Feasibility of Community Psychosocial Intervention for Women N/A
Recruiting NCT06079853 - Nurse Suicide: Physiologic Sleep Health Promotion Trial N/A
Completed NCT05881681 - A Mindfulness Approach to UA for Afro-descendants N/A
Recruiting NCT05449002 - Digital Single Session Intervention for Youth Mental Health N/A
Recruiting NCT04038190 - A Behavioral Activation Intervention Administered in a College Freshman Orientation Course Phase 2
Completed NCT03931772 - Online Automated Self-Hypnosis Program N/A
Active, not recruiting NCT05998161 - Evaluating the Effectiveness of a Digital Therapeutic (Reviga) for People With Stress or Burnout N/A
Completed NCT03728062 - Mindfulness Meditation Versus Physical Exercise: Comparing Effects on Stress and Immunocompetence N/A
Terminated NCT04367636 - The Effects of Attention Training on Emotion Regulation and Stress Related Complaints During COVID-19 N/A
Completed NCT06405789 - The Effect of Yoga on Mindfulness and Perceived Stress N/A
Recruiting NCT06002074 - SMART Program Impact on Quality of Life in Inflammatory Bowel Diseases N/A
Recruiting NCT05273996 - Predictors of Cognitive Outcomes in Geriatric Depression Phase 4
Completed NCT05245409 - Stress, EEG, ECG, and Chiropractic N/A
Completed NCT04722367 - Being Present With Art: The Impact of Mindful Engagement With Art on Awareness and Connection N/A
Recruiting NCT06273228 - Parenting Young Children in Pediatrics N/A
Completed NCT06057883 - Effects Of A Probiotic Formulation On Stress and Skin Health in Younger Adult Females Phase 2
Completed NCT05312749 - The Effect of Web Based Progressive Muscle Relaxation Exercise on Clinical Stress and Anxiety of Nursing Students N/A
Completed NCT05063305 - Probiotics, Immunity, Stress, and QofL N/A
Completed NCT05623826 - Feasibility and Efficacy of a Digital Training Intervention to Increase Reward Sensitivity- Imager N/A
Completed NCT04013451 - The Kiss of Kindness Study II N/A